PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 561.00
-9.00 (-1.58%)
At close: Jul 31, 2026
PeopleBio Revenue
PeopleBio had revenue of 1.67B KRW in the quarter ending June 30, 2026, with 137.19% growth. This brings the company's revenue in the last twelve months to 3.84B, up 119.85% year-over-year. In the year 2025, PeopleBio had annual revenue of 2.85B with 12.64% growth. That makes PeopleBio the 41,544th largest company in the world by revenue and 2,542nd in South Korea.
Revenue (ttm)
3.84B
Revenue Growth
+119.85%
P/S Ratio
3.55
Revenue / Employee
147.58M
Employees
26
Market Cap
13.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.85B | 319.91M | 12.64% |
| Dec 31, 2024 | 2.53B | -1.92B | -43.17% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GC Medical Science | 102.16B |
| Seoulin Bioscience | 83.17B |
| Cytogen | 27.38B |
| Protia | 17.75B |
| HLB Panagene | 14.71B |
| 3billion | 11.71B |
| GENINUS | 11.28B |
| Median Diagnostics | 7.86B |